Mangalam Drugs & Organics Limited

NSE MANGALAM.NS

Mangalam Drugs & Organics Limited Interest Coverage Ratio for the year ending March 31, 2024: -0.05

Mangalam Drugs & Organics Limited Interest Coverage Ratio is -0.05 for the year ending March 31, 2024, a -104.07% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Mangalam Drugs & Organics Limited Interest Coverage Ratio for the year ending March 31, 2023 was 1.17, a -78.27% change year over year.
Mangalam Drugs & Organics Limited Interest Coverage Ratio for the year ending March 31, 2022 was 5.40, a -30.06% change year over year.
Mangalam Drugs & Organics Limited Interest Coverage Ratio for the year ending March 31, 2021 was 7.72, a 217.27% change year over year.
Mangalam Drugs & Organics Limited Interest Coverage Ratio for the year ending March 31, 2020 was 2.43, a 453.34% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

NSE: MANGALAM.NS

Mangalam Drugs & Organics Limited

CEO	Mr. Govardhan Murlidhar Dhoot
IPO Date	May 23, 2005
Location	India
Headquarters	Rupam Building
Employees	432
Sector	Healthcare
Industries Chemicals & Advanced Materials Clinical Trials Drugstores & Retail Pharmacies Fertilizers Pharmaceuticals

Description

Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India.

Key trends

Past 5 years